These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8490080)

  • 41. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
    Hoshino E; Umeda N; Sano J; Miki K; Yahagi N; Oka M; Kimura M; Miyashita H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S72-4. PubMed ID: 7594346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
    Ogoshi K; Kato T; Sakagawa T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
    Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
    Berstad A; Hatlebakk JG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
    Furuta T; Futami H; Arai H; Hanai H; Kaneko E
    J Clin Gastroenterol; 1995; 20 Suppl 2():S107-11. PubMed ID: 7594323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A trial of lansoprazole in refractory gastric ulcer.
    van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
    Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute treatment of duodenal ulcer: experience with lansoprazole.
    Mignon M; Vallot T
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():37-40, discussion 61-6. PubMed ID: 8490078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
    Gough AL; Long RG; Cooper BT; Fosters CS; Garrett AD; Langworthy CH
    Aliment Pharmacol Ther; 1996 Aug; 10(4):529-39. PubMed ID: 8853756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.